EUVIMEDEUVIMED entdecken
Crossref

Human Pancreas‐Derived Organoids with Controlled Polarity: Detailed Protocols and Experimental Timeline

Aletta Kiss iD, Attila Farkas, Ferhan Ayaydin, György Lázár, Árpád Varga iD, József Maléth iD

Current Protocols · 2024

DOI: 10.1002/cpz1.70045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols, 2024. Verfasst von Aletta Kiss und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: Organoids, Pancreas. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since their discovery, 3D cell cultures have emerged as powerful tools across various basic, translational research, and industrial discovery projects. One such application is in the physiological and pathophysiological modeling of pancreatic exocrine functions, which addresses critical clinical challenges, including acute and chronic pancreatitis. While several methods now exist for generating epithelial organoids (derived from induced pluripotent, embryonic, or adult stem cells), the advent of patient‐derived organoids (PDOs) with controlled polarity has introduced a new frontier in pancreatic research. This advancement has significantly expanded the methodological arsenal available for studying human pancreatic epithelial secretion. In this article, we present basic protocols and a troubleshooting guide for an advanced culture method that results in an apical‐to‐basal polarity switch. Alongside the protocols, we emphasize a comprehensive cost breakdown, an aspect often challenging to estimate when implementing new techniques. By sharing the technical nuances and financial implications of these protocols, we aim to encourage researchers to transition from rodent models to primary human epithelial cells wherever feasible. This aligns with the U.S. Environmental Protection Agency's efforts to accelerate the translation of significant scientific findings to address major clinical needs. © 2024 Wiley Periodicals LLC. Basic Protocol 1 : Establishment and maintenance of pancreatic PDOs Basic Protocol 2 : Cryopreservation and thawing of pancreatic PDOs Basic Protocol 3 : Inducing polarity switching in pancreatic PDOs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsPancreasHumansCell PolarityCell Culture TechniquesCryopreservationEpithelial Cells

Stichwörter der Autor:innen

3D cultureapical‐outductal cellorganoidpancreas

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Szeged, Szeged, Hungary.
  • ELRN-USZ Momentum Epithelial Cell Signaling and Secretion Research Group, University of Szeged, Szeged, Hungary.
  • HCEMM-USZ Molecular Gastroenterology Research Group, University of Szeged, Szeged, Hungary.
  • HCEMM-USZ Functional Cell Biology and Immunology Advanced Core Facility, University of Szeged, Szeged, Hungary.
  • Department of Surgery, University of Szeged, Szeged, Hungary.
  • These authors contributed equally to this work.

ORCID-Profile: Aletta Kiss, Árpád Varga, József Maléth

Zitieren

APA

Kiss, A., Farkas, A., Ayaydin, F., Lázár, G., Varga, Á., & Maléth, J. (2024). Human Pancreas‐Derived Organoids with Controlled Polarity: Detailed Protocols and Experimental Timeline. Current Protocols. https://doi.org/10.1002/cpz1.70045

Vancouver

Kiss A, Farkas A, Ayaydin F, Lázár G, Varga Á, Maléth J. Human Pancreas‐Derived Organoids with Controlled Polarity: Detailed Protocols and Experimental Timeline. Current Protocols. 2024. doi:10.1002/cpz1.70045

BibTeX
@article{Kiss2024,
  author = {Kiss, Aletta and Farkas, Attila and Ayaydin, Ferhan and Lázár, György and Varga, Árpád and Maléth, József},
  title = {Human Pancreas‐Derived Organoids with Controlled Polarity: Detailed Protocols and Experimental Timeline},
  journal = {Current Protocols},
  year = {2024},
  doi = {10.1002/cpz1.70045}
}
Kostenlos starten →